✦ LIBER ✦

Novel Market Access Models for Cancer Drugs

✍ Scribed by Aggarwal, S.; Kumar, S.; Topaloglu, H.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Novel Reimbursement Models For Cancer Dr

✍ Aggarwal, S.; Topaloglu, H.; Messenger, M. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PHP156 Novel Drug Reimbursement Models:

✍ S. Aggarwal 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Market access of cancer drugs in Europea

✍ Pauwels, Kim; Huys, Isabelle; Casteels, Minne; De Nys, Katelijne; Simoens, Steve 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 330 KB

DU3 Market Access Delays for CNS Drugs i

✍ S.J.A. Flostrand; L. Anderson; G. Esposito 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

PCN139 OPTIMISING MARKET ACCESS FOR ONCO

✍ H Dummett; B Shankland 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

PHP32 Market Access Variation for Lifest

✍ A.W. Bastian; S. Gea-Sanchez; M. Tangari 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB